DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Samsca (Tolvaptan) - Thirst - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Thirst (45)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Samsca (Tolvaptan) where reactions include thirst. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 45   Next >>

Possible Samsca side effects in 67 year old male

Reported by a physician from Japan on 2012-08-09

Patient: 67 year old male, weighing 53.0 kg (116.6 pounds)

Reactions: White Blood Cell Count Decreased, Hypotension, Thirst

Drug(s) suspected as cause:
Premient (Hydrochlorothiazide, Losartan Potassium) Tablet
    Dosage: 1 df dosage form, daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2011-12-18

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2011-12-13
    End date: 2011-12-24

Other drugs received by patient: Eplerenone; Tenomin (Atenolol) Tablet; Warfarin Sodium; Halfdigoxin (Digoxin) Tablet; Amoban (Zopiclone) Tablet; Ticlopidine HCL; Lasix



Possible Samsca side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-03

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Vomiting, Pruritus, Nausea, Rapid Correction of Hyponatraemia, General Physical Health Deterioration, Thirst, Blood Sodium Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-14

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-14

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-25
    End date: 2012-02-25

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-25
    End date: 2012-02-25

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: 15 mg daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-17
    End date: 2012-01-17

Other drugs received by patient: Saline (Saline), 0.9% Percent; Travegil (Clemastine); Prednisolon (Prednisolone Sodiuim Succinate); Clemastine Fumarate; Levothyroxine Sodium; Riopan (Magaldrate); Metoprolol Succinate; Emend; Pantozol (Pantoprazole); Fenofibrate; Emend (Apepitant); Metoclopramide; Nulytely; Granisetron (Granisetron Hydrochloride); Dimenhydrinate; Atacand; Metoclopramide Hydrochloride; Carboplatin; Ranitidine Hydrochloride; Bezafibrat (Bezafibrate); Zofran; Fortecortin (Dexamethasone); Riopan (Magaldrate); Zofran; Dimenhydrinate; Fraxiparin (Nadroparin Calciium); Zantac; Nacl (Nacl); Haldol; Fortecortin (Dexamethasone); Emend; Hyoscine HBR HYT; Pantoprazole Sodium; Ranitidine Hydrochloride; Etoposide; Novalgin (Metamizole Sodium); Vergentan (Alizapride Hydrochloride)



Possible Samsca side effects in 72 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 72 year old female, weighing 52.9 kg (116.4 pounds)

Reactions: Haemoglobin Decreased, Pneumonia, Blood Urea Increased, Thirst

Drug(s) suspected as cause:
Hanp (Carperitide) Injection
    Dosage: 2000 mcg, daily dose, intravenous
    Indication: Cardiac Failure Congestive
    Start date: 2012-05-30
    End date: 2012-06-04

Lasix
    Dosage: 60 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure Congestive
    Start date: 2012-05-27
    End date: 2012-06-08

Lasix
    Dosage: 40 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure Congestive

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral, 15 mg milligram(s) qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-06-01

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral, 15 mg milligram(s) qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-31
    End date: 2012-05-31

Other drugs received by patient: Rocephin; Nexium; Nauzelin (Domperidone); Aromasin; Hisinalo (Glucose, Potassium Chloride, Sodium Lactate); Osteluc (Etodolac); Solita-T1 (Glucose, Sodium Chloride, Sodium Lactate); Warfarin Sodium; Norvasc; Oxycontin



Possible Samsca side effects in 83 year old female

Reported by a physician from Japan on 2012-07-26

Patient: 83 year old female, weighing 43.0 kg (94.6 pounds)

Reactions: Renal Impairment, Cardiac Failure, Disseminated Intravascular Coagulation, Condition Aggravated, Hypernatraemia, Thirst

Adverse event resulted in: death

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), qam, oral ; 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-19
    End date: 2012-05-28

Samsca
    Dosage: 15 mg milligram(s), qam, oral ; 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-29
    End date: 2012-05-29

Other drugs received by patient: Lasix; Urinorm (Benzbromarone); Lansoprazole; Doputamin (Dobutamine Hydrochloride); Sodium Polystyrene Sulfonate; Meropenem



Possible Samsca side effects in 84 year old male

Reported by a physician from Japan on 2012-07-25

Patient: 84 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Anaemia, Thirst

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Lasix; Aldactone; Torsemide



Possible Samsca side effects in 72 year old female

Reported by a physician from Japan on 2012-07-17

Patient: 72 year old female, weighing 52.9 kg (116.4 pounds)

Reactions: Haemoglobin Decreased, Pneumonia, Blood Urea Increased, Respiratory Failure, Pulmonary Congestion, Pleural Effusion, Thirst, Infection

Drug(s) suspected as cause:
Hanp (Carperitide) Injection
    Dosage: 2000 mcg, daily dose, intravenous
    Indication: Cardiac Failure Congestive
    Start date: 2012-05-30
    End date: 2012-06-04

Lasix
    Dosage: 40 mg milligram(s),
    Indication: Cardiac Failure Congestive

Lasix
    Dosage: 60 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure Congestive
    Start date: 2012-05-27
    End date: 2012-06-08

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-06-01

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-31
    End date: 2012-05-31

Other drugs received by patient: Oxycontin; Hisinaic (Glucose, Potassium Chloride, Sodium Lactate); Solita-T1 (Glucose, Sodium Chloride, Sodium Lactate); Aromasin; Rocephin; Nauzelin (Domperidone); Osteluc (Elodolac); Norvasc; Warfarin Sodium; Nexium



Possible Samsca side effects in 83 year old female

Reported by a physician from Japan on 2012-07-06

Patient: 83 year old female, weighing 43.0 kg (94.6 pounds)

Reactions: Renal Impairment, Cardiac Failure, Disseminated Intravascular Coagulation, Condition Aggravated, Thirst, Hypernatraemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Sodium Polystyrene Sulfonate; Lasix; Lansoprazole; Urinorm (Benzbromarone); Doputamin (Doputamine Hydrochloride); Meropenem



Possible Samsca side effects in 72 year old female

Reported by a physician from Japan on 2012-07-02

Patient: 72 year old female, weighing 52.9 kg (116.4 pounds)

Reactions: Haemoglobin Decreased, Blood Urea Increased, Thirst, Urine Output Increased

Drug(s) suspected as cause:
Hanp (Carperitide) Injection
    Dosage: 2000 mcg, daily dose, intravenous
    Indication: Cardiac Failure Congestive
    Start date: 2012-05-30
    End date: 2012-06-04

Lasix
    Dosage: 40 mg milligram(s), daily dose oral
    Administration route: Oral
    Indication: Cardiac Failure Congestive

Lasix
    Dosage: 60 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure Congestive
    Start date: 2012-05-27
    End date: 2012-06-08

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral : 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-21
    End date: 2012-05-31

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral : 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-06-01

Other drugs received by patient: Warfarin Sodium; Rocephin; Nexium; Osteluc (Etodolac); Nauzelin (Domperidone); Solita-T1 (Glucose, Sodium Chloride, Sodium Lacate); Norvasc; Meropen (Meropenem); Oxycontin; Aromasin; Hisinalc (Glucose, Potassium Chloride, Sodium Lactate)



Possible Samsca side effects in 83 year old male

Reported by a physician from Japan on 2012-06-28

Patient: 83 year old male, weighing 69.0 kg (151.8 pounds)

Reactions: Thirst, Pemphigoid

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Carvedilol; Warfarin Sodium; Lansoprazole; Plavix; Verapamil Hydrochloride; Aldactone; Lasix; Aspirin; Lasix; Olmesartan Medoxomil



Possible Samsca side effects in 80 year old male

Reported by a physician from Japan on 2012-06-27

Patient: 80 year old male, weighing 96.0 kg (211.2 pounds)

Reactions: Pulmonary Hypertension, Dyspnoea, Blood Urea Increased, Haematuria, Condition Aggravated, Thirst, Arrhythmia, Generalised Oedema, Haemoglobin Decreased, RED Blood Cell Count Decreased, Ventricular Tachycardia, Cardiac Failure Congestive

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), qpm, oral, 15 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-09
    End date: 2012-02-14

Samsca
    Dosage: 15 mg milligram(s), qpm, oral, 15 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-30
    End date: 2012-01-30

Samsca
    Dosage: 15 mg milligram(s), qpm, oral, 15 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-31
    End date: 2012-02-07

Other drugs received by patient: Hanp (Carperitide) Injection; Kremezin (Charcoal, Activated) Granules; Revatio (Sildenafil Citrate) Tablet; Careload LA (Beraprost Sodium) Tablet; Diart (Azosemide) Tablet; Lasix; Indapamide; Carvedilol; Urinorm (Benzbromarone) Tablet; Lasix



Possible Samsca side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Vomiting, Nausea, Rapid Correction of Hyponatraemia, General Physical Health Deterioration, Thirst

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-17
    End date: 2012-04-18

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-17
    End date: 2012-04-18

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-20
    End date: 2012-04-21

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-20
    End date: 2012-04-21

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-23

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-23

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-14
    End date: 2012-04-14

Samsca
    Dosage: see image
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-14
    End date: 2012-04-14

Other drugs received by patient: Pantoprazole Sodium; Emend; Zofran; Dexamethasone Sodium Posphate; Nulytely; Pantoprazole Sodium; Granisetron (Granisetron Hydrochloride); Ranitidine Hydrochloride; Vergentan (Alizapride Hydrochloride); Ranitidine Hydrochloride; Zofran; Metoclopramide; Riopan (Magaldrate) Gel; Levothyroxine Sodium; Dimenhydrinate; Carboplatin; Etoposide; Novalgin (Metamizole Sodium); Clemastine Fumarate; Dexamethasone Sodium Posphate; Prednisolon (Prednisolone Sodium Succinate); Zantac; Saline (Saline) 0.9%; Saline (Saline) 10%; Haldol; Dimenhydrinate; Riopan (Magaldrate) Gel; Saline (Saline) 0.68%; Fenofibrate; Bezafibrat (Bezafibrate); Metoprolol Succinate; Nacl (Nacl); Atacand; Metoclopramide Hydrochloride; Emend; Tavegil (Clemastine) Tablet; Fraxiparin (Nadroparin Calcium); Buscopan (Hyoscine Butylbromide) Capsule; Emend



Possible Samsca side effects in 61 year old male

Reported by a physician from Japan on 2012-06-19

Patient: 61 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Renal Impairment, Hyperkalaemia, Cardiac Failure, Condition Aggravated, Thirst, Hyperuricaemia, Urine Output Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-16

Hanp (Carperitide(genetical Recombination)) Injection
    Dosage: 2000 mcg, daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2011-12-06
    End date: 2011-12-12

Lasix
    Dosage: 40 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2011-12-06
    End date: 2012-01-06

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2011-12-23
    End date: 2012-02-07

Venectomin (Potassium Canrenoate) Injection
    Dosage: 100 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2011-12-15
    End date: 2011-12-15

Other drugs received by patient: Carvedilol; Adalat; Diovan; Crestor; Warfarin Sodium; Magmitt (Magnesium Oxide); Pimobendan (Pimobendan); Novolin 30R (Insulin Human, Insulin Human Injection, Isophane); Novorapid (Insulin Aspart)genetical Recombination)); Plavix; Novo Heparin (Heparin); Bisoprolol Fumarate; Basen (Voglibose); Humulin N; Xylocaine



Possible Samsca side effects in 83 year old female

Reported by a physician from Japan on 2012-06-15

Patient: 83 year old female, weighing 43.0 kg (94.6 pounds)

Reactions: Renal Impairment, Disseminated Intravascular Coagulation, Condition Aggravated, Blood Sodium Increased, Thirst, Cardiac Failure Congestive, Anuria

Adverse event resulted in: death

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), qam, oral 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-19
    End date: 2012-05-28

Samsca
    Dosage: 15 mg milligram(s), qam, oral 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-05-29
    End date: 2012-05-29

Other drugs received by patient: Urinorm (Benzbromarone) Tablet; Meropenem; Lansoprazole; Kalimate (Calcium Polystyrene Sulfonate) Oral Powder; Lasix; Doputamin (Dobutamine Hydrochloride) Injection; Meropenem; Doputamin (Dobutamine Hydrochloride) Injection; Doputamin (Dobutamine Hydrochloride) Injection; Doputamin (Dobutamine Hydrochloride) Injection



Possible Samsca side effects in 57 year old male

Reported by a physician from Japan on 2012-06-15

Patient: 57 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Ventricular Tachycardia, Polyuria, Thirst, Blood Pressure Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aldactone
    Dosage: unk, oral
    Administration route: Oral

Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-01-21

Lasix
    Dosage: 10 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2012-01-18

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-19
    End date: 2012-01-21

Spironolactone
    Dosage: 25 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-01-21

Other drugs received by patient: Lendem (Brotizolam) Tablet; Warfarin Sodium; Furosemide; Rabeprazole Sodium; Herpamine (Denopamine) Tablet; Carvedilol; Vitamedin (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride) INJ; Slow-K; Dobupum (Dobutamine Hydrochloride) Injection; Ferromia (Ferrous Sodium Citrate); KCI (Kci) Injection; Depas (Etizolam); Luprac (Torasemide) Tablet; Halfdigoxin (Digoxin) Tablet; Harnal (Tamsulosin Hydrochloride) Tablet



Possible Samsca side effects in 69 year old male

Reported by a physician from Japan on 2012-06-15

Patient: 69 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Renal Impairment, Hyperkalaemia, Thirst, Hyperuricaemia

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg (milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-26
    End date: 2012-01-11

Lasix
    Dosage: 40 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-26
    End date: 2012-02-15

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2011-12-28
    End date: 2012-01-27

Other drugs received by patient: Rocephin; Bisoprolol Fumarate; Hanp (Carperitide) Injection; Novo Heparin (Heparin) Injection; Verapamil Hydrochloride; Lantus; Novorapid (Insulin Aspart) Injection; Lasix; Landel (Efonidipine Hydrochloride) Tablet; Diovan; Zithromax; Adetphos (Adenosine Triphosphate, Disodium Salt) Injection; Actos; Vasolan (Verapamil Hydrochloride) Injection; Warfarin Sodium



Possible Samsca side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-15

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Vomiting, Nausea, Rapid Correction of Hyponatraemia, General Physical Health Deterioration, Thirst

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    End date: 2012-04-23

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    End date: 2012-04-23

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    End date: 2012-04-23

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-04-17
    End date: 2012-04-18

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-17
    End date: 2012-04-18

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-17
    End date: 2012-04-18

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-04-14
    End date: 2012-04-14

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-14
    End date: 2012-04-14

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-14
    End date: 2012-04-14

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-04-20
    End date: 2012-04-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-20
    End date: 2012-04-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-20
    End date: 2012-04-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral, oral
    Administration route: Oral
    Indication: Inappropriate Antidiuretic Hormone Secretion
    Start date: 2012-04-12
    End date: 2012-04-12

Other drugs received by patient: Fenofibrate; Carboplatin; Levothyroxine Sodium; Metoclopramide Hydrochloride; Riopan (Magaldrate) Gel; Vergentan (Alizapride Hydrochloride); Nacl (Naci); Saline (Saline); Tavegil (Clemastine) Tablet; Nulytely; Haldol; Riopan (Magaldrate) Gel; Pantoprazole Sodium; Dimenhydrinate; Metoclopramide; Pantoprazole Sodium; Atacand; Zofran; Bezafibrat (Bezafibrate); Metoprolol Succinate; Novalgin (Metamizole Sodium); Granisetron (Granisetron Hydrochloride); Prednisolon (Prednisolone Sodium Succinate); Dexamethasone Sodium Posphate; Emend; Etoposide; Buscopan (Hyoscine Butylbromide) Capsule; Ranitidine Hydrochloride; Fraxiparin (Nadroparin Calcium); Ranitidine Hydrochloride; Zantac



Possible Samsca side effects in 63 year old male

Reported by a physician from Japan on 2012-06-11

Patient: 63 year old male, weighing 52.0 kg (114.4 pounds)

Reactions: Productive Cough, Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Anaphylactic Shock, Hypernatraemia, Pyrexia, Thirst, Hyperhidrosis, Somnolence, Multi-Organ Failure, Generalised Erythema, Cerebral Artery Embolism, Pleural Effusion, Melaena, White Blood Cell Count Increased, Demyelination, Blood Urea Increased, Hyperglycaemia, Malnutrition, Diarrhoea, Dehydration, Mental Disorder, Depressed Level of Consciousness, Blood Pressure Decreased, Altered State of Consciousness

Adverse event resulted in: death

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg milligram(s), qd, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-05-09
    End date: 2012-05-13

Humulin R (Insuin Human) Injection
    Dosage: subcutaneous
    Indication: Hyperglycaemia
    Start date: 2012-05-19

Lasix
    Dosage: 20 mg milligram(s), qd, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-05-09
    End date: 2012-05-13

Omeprazole
    Dosage: intravenous
    Start date: 2012-05-16

Samsca
    Dosage: 15 mg milligram(s), qd, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-05-11
    End date: 2012-05-13

Other drugs received by patient: Zosyn (Piperacilin Sodium, Tazobactam Sodium); Isosorbide Dinitrate; Lasix; Famotidine; Magmitt (Magnesium Oxide); Carvedilol; LQC-B (Bifidobacterium Lactis); Nitroderm; Vitamin Preparations (Vitamins Preparations); Zantac; Picillibacta (Ampicillin Sodium, Sulbactam Sodium); Miya BM (Clostridium Butyricum); Iron Preparations (Iron Preparations); Hanp (Carperitide); Gaslon N (Irsogladine Maleate); Blood Substitutes (Blood Substitutes)



Possible Samsca side effects in 80 year old male

Reported by a physician from Japan on 2012-06-08

Patient: 80 year old male, weighing 96.0 kg (211.2 pounds)

Reactions: Dyspnoea, Ventricular Tachycardia, Haematuria, Thirst, Generalised Oedema

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), qpm, oral, 15 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-09
    End date: 2012-02-14

Samsca
    Dosage: 15 mg milligram(s), qpm, oral, 15 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-30
    End date: 2012-01-30

Samsca
    Dosage: 15 mg milligram(s), qpm, oral, 15 mg milligram(s), qam, oral, 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-31
    End date: 2012-02-07

Other drugs received by patient: Hanp (Carperitide); Revatio; Lasix; Carvedilol; Diart (Azosemide); Indapamide; Kremezin (Charcoal, Activated); Urinorm (Benzbromarone); Lasix; Careload LA (Beraprost Sodium)



Possible Samsca side effects in 83 year old male

Reported by a physician from Japan on 2012-06-08

Patient: 83 year old male, weighing 69.0 kg (151.8 pounds)

Reactions: Thirst, Pemphigoid

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Lasix; Aspirin; Aldactone; Lansoprazole; Carvedilol; Olmesartan Medoxomil; Verapamil Hydrochloride; Plavix; Warfarin Sodium



Possible Samsca side effects in 58 year old male

Reported by a physician from Japan on 2012-06-06

Patient: 58 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: Thirst

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Atelec (Clinidipine); Coretec (Olprinone Hydrochloride); Micardis; Lasix; Hanp (Carperitide)



Possible Samsca side effects in 80 year old male

Reported by a physician from Japan on 2012-05-24

Patient: 80 year old male, weighing 96.0 kg (211.2 pounds)

Reactions: Haemoglobin Decreased, Blood Urea Increased, RED Blood Cell Count Decreased, Ventricular Tachycardia, Thirst

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Lasix; Careload LA (Beraprost Sodium); Diart (Azosemide); Lasix; Urinorm (Enzbromarone); Remezin (Charcoal, Activated); Revatio; Indapamide; Carvedilol; Hanp (Carperitide)



Possible Samsca side effects in 57 year old male

Reported by a physician from Japan on 2012-05-18

Patient: 57 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Ventricular Tachycardia, Polyuria, Thirst, Blood Pressure Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aldactone
    Dosage: oral
    Administration route: Oral

Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-01-21

Lasix
    Dosage: 10 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2012-01-18

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-19
    End date: 2012-01-21

Spironolactone
    Dosage: 25 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-01-21

Other drugs received by patient: Herpamine (Denopamine); Depas (Etizolam); Furosemide; Dobupum (Dobutamine Hydrochloride); Warfarin Sodium; Ferromia (Ferrous Sodium Citrate); Xylocaine; Slow-K; KCI (Kci); Rabeprazole Sodium; Vitamedin (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride); Torsemide; Tamsulosin Hydrochloride; Carvedilol; Lendem (Brotizolam); Digoxin



Possible Samsca side effects in 61 year old male

Reported by a physician from Japan on 2012-05-18

Patient: 61 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Renal Impairment, Hyperkalaemia, Cardiac Failure, Thirst, Hyperuricaemia, Urine Output Increased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-16

Hanp (Carperitide(genetical Recombination)) Injection
    Dosage: 2000 mcg, daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2011-12-06
    End date: 2011-12-12

Lasix
    Dosage: 40 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2011-12-06
    End date: 2012-01-06

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2011-12-23
    End date: 2012-02-07

Venectomin (Potassium Canrenoate) Injection
    Dosage: 100 mg milligram(s), daily dose, intravenous
    Indication: Cardiac Failure
    Start date: 2011-12-15
    End date: 2011-12-15

Other drugs received by patient: Plavix; Diovan; Humulin N; Magmitt (Magnesium Oxide); Novo Heparin (Heparin); Xylocaine; Warfarin Sodium; Pimobendan (Pimobendan); Basen (Voglibose); Bisoprolol Fumarate; Adalat; Crestor; Novolin 30R (Insulin Human, Insulin Human Injection, Isophane); Carvedilol; Novorapid (Insulin Aspart(genetical Recombination))



Possible Samsca side effects in 69 year old male

Reported by a physician from Japan on 2012-05-17

Patient: 69 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Renal Impairment, Hyperkalaemia, Thirst, Hyperuricaemia

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-26
    End date: 2012-01-11

Lasix
    Dosage: 40 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-26
    End date: 2012-02-15

Samsca
    Dosage: 15 mg milligram(s), gam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2011-12-28
    End date: 2012-01-27

Other drugs received by patient: Lantus (Insuline Glargine); Landel (Efonidipine Hydrochloride); Zithromax; Verapamil Hydrochloride; Rocephin; Novolog; Warfarin Sodium; Verapamil Hydrochloride; Adetphos (Adenosine Triphosphate, Disodium Salt); Diovan; Novo Heparin (Heparin); Bisoprolol Fumarate; Hanp (Carperitide); Actos



Possible Samsca side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-15

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Vomiting, Nausea, Rapid Correction of Hyponatraemia, Hyponatraemia, General Physical Health Deterioration, Thirst

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-14
    End date: 2012-04-14

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-02
    End date: 2012-02-02

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-22
    End date: 2012-02-22

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-12
    End date: 2012-04-12

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2011-12-21
    End date: 2011-12-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-03-30
    End date: 2012-04-08

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-17
    End date: 2012-04-18

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-20
    End date: 2012-04-21

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-17
    End date: 2012-01-17

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-02-28
    End date: 2012-03-26

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-01-09
    End date: 2012-01-09

Samsca
    Dosage: 15 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Hyponatraemia
    Start date: 2012-04-23

Other drugs received by patient: Fenofibrate; Ofran (Ondansetron); Dexamethasone Sodium Posphate; Dimenhydrinate; Granisetron (Granisetron Hydrochloride); Clemastine Fumarate; Naci (Nacl); Nulytely; Metoprolol Succinate; Levothyroxine Sodium; Ranitidine Hydrochloride; Clemastine Fumarate; Bezafibrat (Bezafibrate); Prednisolon (Prednisolone Sodium Succinate); Riopan (Magaldrate); Emend; Etoposide; Fraxiparin (Nadrparin Calcium); Buscopan (Hyoscine Hutylbromide); Metoclopramide; Vergentan (Alizapride Hydrochloride); Atacand; Metoclopramide Hydrochloride; Novalgin (Metamizole Sodium); Saline (Saline); Dimenhydrinate; Carboplatin; Ranitidine Hydrochloride; Pantoprazole Sodium; Haldol; Pantoprazole Sodium



Possible Samsca side effects in 90 year old male

Reported by a physician from Japan on 2012-05-09

Patient: 90 year old male, weighing 34.0 kg (74.8 pounds)

Reactions: Hyponatraemia, Thirst

Drug(s) suspected as cause:
Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral; 30 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-02-28

Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral; 30 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-02-27

Furosemide
    Dosage: 40 mg milligram(s), daily dose, oral; 20 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-02-27

Furosemide
    Dosage: 40 mg milligram(s), daily dose, oral; 20 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-02-28

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral; 15 mg milligram(s), qam, oral; 7,5 mg milligram(s),qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-18
    End date: 2012-02-22

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral; 15 mg milligram(s), qam, oral; 7,5 mg milligram(s),qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-23
    End date: 2012-02-25

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral; 15 mg milligram(s), qam, oral; 7,5 mg milligram(s),qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-26

Other drugs received by patient: Daikentyuto (Herbal Extract Nos); Marzulene S (Levoglutamide, Sodium Gualenate); Aspirin; Lendormin (Brotizalm); Allopurinol; Aldactone; Omeprazole; Digoxin; Frandol (Isosorbide Dinitrate) Transdermal Patch; Pletal



Possible Samsca side effects in 87 year old male

Reported by a physician from Japan on 2012-05-08

Patient: 87 year old male, weighing 76.0 kg (167.2 pounds)

Reactions: Thirst

Drug(s) suspected as cause:
Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure

Lasix
    Dosage: 40 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure

Samsca
    Dosage: 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-10
    End date: 2012-02-24

Other drugs received by patient: Kremezin (Charcoal, Activated); Lansoprazole; Coughnol (Ambroxol Hydrochloride); Warfarin Sodium; Glucose (Ascorbic Acid, Glucose); Calblock (Azelnidipine); Promac (Polaprezinc); Atelec (Cilnidipine); Magmitt (Magnesium Oxide); Allopurinol; Yodel S (Senna Extract); Hanp (Carperitide)



Possible Samsca side effects in 58 year old male

Reported by a physician from Japan on 2012-05-01

Patient: 58 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: Blood Urea Increased, Thirst, Blood Creatinine Increased

Drug(s) suspected as cause:
Samsca

Other drugs received by patient: Hanp (Carperitide); Micardis; Atelec (Cilnidipine); Lasix; Coretec (Olprinone Hydrochloride)



Possible Samsca side effects in 90 year old male

Reported by a physician from Japan on 2012-04-30

Patient: 90 year old male, weighing 34.0 kg (74.8 pounds)

Reactions: Potentiating Drug Interaction, Hyponatraemia, Thirst

Drug(s) suspected as cause:
Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral ; 30 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-02-27

Diart (Azosemide) Tablet
    Dosage: 60 mg milligram(s), daily dose, oral ; 30 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-02-28

Furosemide
    Dosage: 40 mg milligram(s), daily dose, oral ; 20 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-02-28

Furosemide
    Dosage: 40 mg milligram(s), daily dose, oral ; 20 mg milligram(s), daily dose, oral
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2012-02-27

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral ; 15 mg milligram(s), qam, oral ; 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-26

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral ; 15 mg milligram(s), qam, oral ; 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-18
    End date: 2012-02-22

Samsca
    Dosage: 7.5 mg milligram(s), qam, oral ; 15 mg milligram(s), qam, oral ; 7.5 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-23
    End date: 2012-02-25

Other drugs received by patient: Omeprazole; Marzulene S (Levoglutamide, Sodium Gualenate); Isosorbide Dinitrate; Lendorm; Aldactone S (Spironolactone); Allopurinol; Aspirin; Digoxin; Daikentyuto (Herbal Extract Nos); Pletal



Possible Samsca side effects in 80 year old male

Reported by a physician from Japan on 2012-04-16

Patient: 80 year old male, weighing 96.0 kg (211.2 pounds)

Reactions: Haemoglobin Decreased, Blood Urea Increased, RED Blood Cell Count Decreased, Ventricular Tachycardia, Thirst

Drug(s) suspected as cause:
Samsca
    Dosage: 15 mg milligram(s), qpm, oral 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-30
    End date: 2012-01-30

Samsca
    Dosage: 15 mg milligram(s), qpm, oral 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-02-09
    End date: 2012-02-14

Samsca
    Dosage: 15 mg milligram(s), qpm, oral 15 mg milligram(s), qam, oral
    Administration route: Oral
    Indication: Fluid Retention
    Start date: 2012-01-31
    End date: 2012-02-07

Other drugs received by patient: Revatio; Carvedilol; Lasix; Hanp (Carperitide); Indapamide; Careload LA (Beraprost Sodium); Diart (Azosemide); Urinorm (Benzbromarone); Kremezin (Charcoal, Activated); Lasix



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017